164 related articles for article (PubMed ID: 36546304)
1. Supramolecular engineering of cell membrane vesicles for cancer immunotherapy.
Qi S; Zhang H; Zhang X; Yu X; Wang Y; Meng QF; Yang K; Bai B; Tian R; Zhu S; Rao L; Huang F; Yu G
Sci Bull (Beijing); 2022 Sep; 67(18):1898-1909. PubMed ID: 36546304
[TBL] [Abstract][Full Text] [Related]
2. Host-Guest Chemistry in Supramolecular Theranostics.
Yu G; Chen X
Theranostics; 2019; 9(11):3041-3074. PubMed ID: 31244941
[TBL] [Abstract][Full Text] [Related]
3. A Hybrid Supramolecular Polymeric Nanomedicine for Cascade-Amplified Synergetic Cancer Therapy.
Yang K; Qi S; Yu X; Bai B; Zhang X; Mao Z; Huang F; Yu G
Angew Chem Int Ed Engl; 2022 Jul; 61(27):e202203786. PubMed ID: 35384193
[TBL] [Abstract][Full Text] [Related]
4. Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review.
Hu W; Ye B; Yu G; Huang F; Mao Z; Ding Y; Wang W
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110674
[TBL] [Abstract][Full Text] [Related]
5. Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.
Hu W; Ye B; Yu G; Yang H; Wu H; Ding Y; Huang F; Wang W; Mao Z
Adv Sci (Weinh); 2024 May; 11(20):e2305382. PubMed ID: 38493499
[TBL] [Abstract][Full Text] [Related]
6. Suprasomes Based on Host-Guest Molecular Recognition: An Excellent Alternative to Liposomes in Cancer Theranostics.
Yang K; Hua B; Qi S; Bai B; Yu C; Huang F; Yu G
Angew Chem Int Ed Engl; 2022 Dec; 61(52):e202213572. PubMed ID: 36261392
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular chemistry of p-sulfonatocalix[n]arenes and its biological applications.
Guo DS; Liu Y
Acc Chem Res; 2014 Jul; 47(7):1925-34. PubMed ID: 24666259
[TBL] [Abstract][Full Text] [Related]
8. Supramolecular Polymer-Based Nanomedicine: High Therapeutic Performance and Negligible Long-Term Immunotoxicity.
Yu G; Zhao X; Zhou J; Mao Z; Huang X; Wang Z; Hua B; Liu Y; Zhang F; He Z; Jacobson O; Gao C; Wang W; Yu C; Zhu X; Huang F; Chen X
J Am Chem Soc; 2018 Jun; 140(25):8005-8019. PubMed ID: 29874067
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular nanomedicines based on host-guest interactions of cyclodextrins.
Tong F; Zhou Y; Xu Y; Chen Y; Yudintceva N; Shevtsov M; Gao H
Exploration (Beijing); 2023 Aug; 3(4):20210111. PubMed ID: 37933241
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications.
Hu QD; Tang GP; Chu PK
Acc Chem Res; 2014 Jul; 47(7):2017-25. PubMed ID: 24873201
[TBL] [Abstract][Full Text] [Related]
12. PSMA-Targeted Supramolecular Nanoparticles Prepared From Cucurbit[8]uril-Based Ternary Host-Guest Recognition for Prostate Cancer Therapy.
Zhang X; Qi S; Liu D; Du J; Jin J
Front Chem; 2022; 10():847523. PubMed ID: 35223775
[TBL] [Abstract][Full Text] [Related]
13. Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications.
Zhang J; Ma PX
Nano Today; 2010 Aug; 5(4):337-350. PubMed ID: 20725642
[TBL] [Abstract][Full Text] [Related]
14. Host-guest interaction based supramolecular photodynamic therapy systems: a promising candidate in the battle against cancer.
Yang K; Zhang Z; Du J; Li W; Pei Z
Chem Commun (Camb); 2020 Jun; 56(44):5865-5876. PubMed ID: 32432243
[TBL] [Abstract][Full Text] [Related]
15. An overview from simple host-guest systems to progressively complex supramolecular assemblies.
Sayed M; Pal H
Phys Chem Chem Phys; 2021 Dec; 23(46):26085-26107. PubMed ID: 34787121
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-Responsive Molecular Assemblies Based on Host-Guest Chemistry.
Xiao X; Xu Z; Wang W; Sun S; Qiao Y; Jiang L; Yan Y; Huang J
Langmuir; 2021 Jul; 37(27):8348-8355. PubMed ID: 34210141
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy.
Qi S; Zhang X; Yu X; Jin L; Yang K; Wang Y; Feng Y; Lei J; Mao Z; Yu G
Adv Mater; 2024 Mar; ():e2311574. PubMed ID: 38433564
[TBL] [Abstract][Full Text] [Related]
18. Nanoassemblies driven by cyclodextrin-based inclusion complexation.
Kang Y; Guo K; Li BJ; Zhang S
Chem Commun (Camb); 2014 Oct; 50(76):11083-92. PubMed ID: 24970352
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy.
Guo Y; Liu Y; Wu W; Ling D; Zhang Q; Zhao P; Hu X
Biomaterials; 2021 Sep; 276():121018. PubMed ID: 34284200
[TBL] [Abstract][Full Text] [Related]
20. A Facile, Protein-Derived Supramolecular Theranostic Strategy for Multimodal-Imaging-Guided Photodynamic and Photothermal Immunotherapy In Vivo.
Cheng HB; Dai H; Tan X; Li H; Liang H; Hu C; Huang M; Lee JY; Zhao J; Zhou L; Wang Y; Zhang L; Yoon J
Adv Mater; 2022 Mar; 34(11):e2109111. PubMed ID: 35018682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
